Abstract:10644 Background: To evaluate the correlations of clinical pathologic status, expression of tumor markers and prognosis in 5000 Chinese breast cancer. Methods: A series primary operable breast cancers from 2002 to 2005 were studied in Tianjin Cancer Hospital. 55% of them are premenopausal and median age is 45 years old; 45% of them are postmenopausal and median age is 58 years old. All of the cases were reviewed by pathologist. ER, PgR, HER-2, p53, PCNA were measured by imunohistochemistry (IHC). Recurrence or metastasis were seen in 126 cases (median follow-up 30 months). Results: Negative axillary lymph nodes in 49.8%,and nodes positive in 50.2% (1 to 3 nodes positive in 28.3%, 4 to 9 nodes positive in 12.1% and over 10 nodes positive in 9.8%). Hermone receptor were observed in 51.7% ER+, 44.7% PgR+, 36.2% ER+/PgR+, 15.5% ER+/PgR−, 8.5% ER−/PgR+, 39.8% ER−/PgR−. HER-2 were observed in 56.8% her-2(-) ,21.7% her-2(+), 10.4% her-2(++) and 11.1% her-2(+++). p53 were observed in 34.4% (+) and PCNA were observed in 85.9% (+). Conclusions: First, Her-2 expression is shown positive correlation with positive axillary lymph nodes, especially remarkable correlated in the number of positive nodes in premenopausal patients. Second, Her-2 expression is shown negative correlation with ER and PgR. Third, Her-2 expression has no correlation with histologic grades of tumors and in some conditions has positive correlation with p53 and PCNA. Fifth, Her-2 expression has no correlation with recurrence, but positive correlation with distant metastasis. In general, Her-2 expression in breast cancer could be taken as the independent index for predicting prognosis. Status of axillary lymph nodes, expression of ER, PgR are the independent factor for expression of her-2. Expression of p53 and PCNA couldn’t be taken as the independent index for predict prognosis. No significant financial relationships to disclose.

P53 Protein Expression Levels in Stage I Breast Cancer and Its Relationship to Clinico - Pathologic Parameters

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Nup88 Mrna Overexpression in Colorectal Cancers and Relationship with P53

Expression and Significance of P51 Gene in Breast Cancer

Clinical Biology Value of P53 Overexpression in Chinese Breast Cancer by Meta Analysis

Nuclear immunoreaction of p53 as related to prognosis of breast cancer

Prognostic Role of p53 Immunohistochemical Status in Invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].

[Comparison of Nuclear Accumulation of P53 Protein with Mutations in the P53 Gene on the Tissues of Human Breast Cancer].

Clinical Pathologic Status and Expression of Tumor Markers in 5,000 Chinese Breast Cancers

Expressions of Cyclin E and P53 in Breast Cancer and Their Significances

Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma

Clinical Value of P_53 Gene Mutation in Bladder Cancer

Evaluation of Prognosis and Expression of PCNA in the Early Breast Cancer

Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer

[Peripheral Blood Mutated P53 DNA and Its Clinical Value in Human Breast Cancer].

Relationship between expression of multidrug resistance protein,PCNA and p53 and its significance in patients with non-small cell lung cancer

[The Expression of P53, Cyclin D1 and PCNA in Non-Small Cell Lung Cancer].